ASCO Update: A Theme of Accessibility and Pricing Plus Individual Reporting

With the 2021 American Society of Clinical Oncology Annual Meeting now in high gear, there is plenty of news. Here’s a look at just some of the most recent stories.

A Focus on Accessibility and Pricing

Although ASCO is filled with clinical trial updates (see below), there appears to be a theme. That theme is access to drugs, and it was emphasized by the organization’s selection of a late-breaking study about Junshi’s toripalimab, which is the 10th anti-PD-L1 checkpoint inhibitor likely to be launched in the U.S.